Citigroup Inc. lessened its holdings in Amrize Ltd (NYSE:AMRZ – Free Report) by 80.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 458,725 shares of the company’s stock after selling 1,835,410 shares during the quarter. Citigroup Inc. owned approximately 0.08% of Amrize worth $22,133,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in AMRZ. State of Wyoming acquired a new position in Amrize in the 3rd quarter valued at approximately $32,000. Costello Asset Management INC acquired a new stake in Amrize in the third quarter valued at $44,000. Global Retirement Partners LLC acquired a new stake in Amrize in the third quarter valued at $48,000. Jones Financial Companies Lllp bought a new position in Amrize during the 3rd quarter worth $53,000. Finally, BNP Paribas Financial Markets acquired a new position in Amrize during the 2nd quarter worth about $59,000.
Analyst Upgrades and Downgrades
AMRZ has been the subject of several recent research reports. Oddo Bhf initiated coverage on Amrize in a research note on Monday, November 3rd. They issued a “neutral” rating for the company. Oppenheimer reissued an “outperform” rating and set a $70.00 target price (up from $64.00) on shares of Amrize in a research report on Thursday, February 19th. Sanford C. Bernstein restated an “outperform” rating and set a $70.00 price target on shares of Amrize in a report on Thursday, December 18th. Bank of America set a $58.00 price objective on shares of Amrize in a research note on Monday, January 12th. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Amrize in a research note on Monday. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $63.43.
Amrize Price Performance
Amrize stock opened at $64.20 on Friday. The stock has a market capitalization of $35.51 billion and a price-to-earnings ratio of 26.10. Amrize Ltd has a 52-week low of $44.12 and a 52-week high of $65.94. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.10 and a current ratio of 1.64. The stock’s 50 day moving average price is $56.83 and its two-hundred day moving average price is $52.92.
Amrize (NYSE:AMRZ – Get Free Report) last released its earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.59 by $0.03. The company had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.95 billion. The company’s revenue was down .4% on a year-over-year basis.
Insider Buying and Selling at Amrize
In related news, CFO Ian A. Johnston acquired 1,200 shares of the business’s stock in a transaction dated Thursday, February 19th. The shares were bought at an average price of $63.92 per share, with a total value of $76,704.00. Following the transaction, the chief financial officer directly owned 18,544 shares of the company’s stock, valued at $1,185,332.48. This trade represents a 6.92% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Featured Articles
- Five stocks we like better than Amrize
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
